| The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis AM Malfait, R Gallily, PF Sumariwalla, AS Malik, E Andreakos, ... Proceedings of the National Academy of Sciences 97 (17), 9561-9566, 2000 | 851 | 2000 |
| Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS‐4 and ADAMTS‐5 RH Song, M D. Tortorella, AM Malfait, JT Alston, Z Yang, EC Arner, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2007 | 507 | 2007 |
| The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation MD Tortorella, AM Malfait, C Deccico, E Arner Osteoarthritis and cartilage 9 (6), 539-552, 2001 | 409 | 2001 |
| Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage AM Malfait, RQ Liu, K Ijiri, S Komiya, MD Tortorella Journal of Biological Chemistry 277 (25), 22201-22208, 2002 | 379 | 2002 |
| Towards a mechanism-based approach to pain management in osteoarthritis AM Malfait, TJ Schnitzer Nature Reviews Rheumatology 9 (11), 654-664, 2013 | 366 | 2013 |
| Osteoarthritis joint pain: the cytokine connection RE Miller, RJ Miller, AM Malfait Cytokine 70 (2), 185-193, 2014 | 349 | 2014 |
| CCR2 chemokine receptor signaling mediates pain in experimental osteoarthritis RE Miller, PB Tran, R Das, N Ghoreishi-Haack, D Ren, RJ Miller, ... Proceedings of the National Academy of Sciences 109 (50), 20602-20607, 2012 | 282 | 2012 |
| Osteoarthritis year in review 2015: biology AM Malfait Osteoarthritis and Cartilage 24 (1), 21-26, 2016 | 195 | 2016 |
| DBA/1 mice expressing the human TNF-alpha transgene develop a severe, erosive arthritis: characterization of the cytokine cascade and cellular composition. DM Butler, AM Malfait, LJ Mason, PJ Warden, G Kollias, RN Maini, ... Journal of immunology (Baltimore, Md.: 1950) 159 (6), 2867-2876, 1997 | 186 | 1997 |
| Blockade of IL-12 during the induction of collagen-induced arthritis (CIA) markedly attenuates the severity of the arthritis AM Malfait, DM Butler, DH Presky, RN Maini, FM Brennan, M Feldmann Clinical & Experimental Immunology 111 (2), 377-383, 1998 | 185 | 1998 |
| On the predictive utility of animal models of osteoarthritis AM Malfait, CB Little Arthritis research & therapy 17, 1-14, 2015 | 175 | 2015 |
| A commentary on modelling osteoarthritis pain in small animals AM Malfait, CB Little, JJ McDougall Osteoarthritis and Cartilage 21 (9), 1316-1326, 2013 | 168 | 2013 |
| α2-Macroglobulin is a novel substrate for ADAMTS-4 and ADAMTS-5 and represents an endogenous inhibitor of these enzymes MD Tortorella, EC Arner, R Hills, A Easton, J Korte-Sarfaty, K Fok, ... Journal of Biological Chemistry 279 (17), 17554-17561, 2004 | 165 | 2004 |
| ADAMTS-5 deficient mice do not develop mechanical allodynia associated with osteoarthritis following medial meniscal destabilization AM Malfait, J Ritchie, AS Gil, JS Austin, J Hartke, W Qin, MD Tortorella, ... Osteoarthritis and cartilage 18 (4), 572-580, 2010 | 160 | 2010 |
| Proprotein convertase furin interacts with and cleaves pro-ADAMTS4 (Aggrecanase-1) in the trans-Golgi network P Wang, M Tortorella, K England, AM Malfait, G Thomas, EC Arner, D Pei Journal of Biological Chemistry 279 (15), 15434-15440, 2004 | 158 | 2004 |
| Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram. SE Ross, RO Williams, LJ Mason, C Mauri, L Marinova-Mutafchieva, ... Journal of immunology (Baltimore, Md.: 1950) 159 (12), 6253-6259, 1997 | 149 | 1997 |
| The β2-adrenergic agonist salbutamol is a potent suppressor of established collagen-induced arthritis: mechanisms of action AM Malfait, AS Malik, L Marinova-Mutafchieva, DM Butler, RN Maini, ... The Journal of Immunology 162 (10), 6278-6283, 1999 | 148 | 1999 |
| PCSK6-mediated corin activation is essential for normal blood pressure S Chen, P Cao, N Dong, J Peng, C Zhang, H Wang, T Zhou, J Yang, ... Nature medicine 21 (9), 1048-1053, 2015 | 140 | 2015 |
| Translational development of an ADAMTS-5 antibody for osteoarthritis disease modification J Larkin, TA Lohr, L Elefante, J Shearin, R Matico, JL Su, Y Xue, F Liu, ... Osteoarthritis and cartilage 23 (8), 1254-1266, 2015 | 131 | 2015 |
| Anti‐IL‐12 and anti‐TNF antibodies synergistically suppress the progression of murine collagen‐induced arthritis DM Butler, AM Malfait, RN Maini, FM Brennan, M Feldmann European journal of immunology 29 (7), 2205-2212, 1999 | 131 | 1999 |
Rachel MillerRush University Medical Centerยืนยันอีเมลแล้วที่ rush.edu
